Comparison of fludarabine, a myeloablative dose of busulfan, and melphalan vs conventional myeloablative conditioning regimen in patients with relapse and refractory acute myeloid leukemia in non-remission status

Yoshimitsu Shimomura, Masahiko Hara, Shigeki Hirabayashi, Tadakazu Kondo, Shohei Mizuno, Naoyuki Uchida, Junichi Mukae, Toshiro Kawakita, Takahiro Fukuda, Yoshinobu Kanda, Shuichi Ota, Yukiyasu Ozawa, Tetsuya Eto, Yumiko Maruyama, Masatsugu Tanaka, Nobuaki Nakano, Takafumi Kimura, Tatsuo Ichinohe, Yoshiko Atsuta, Masamitsu Yanada

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)2302-2304
Number of pages3
JournalBone Marrow Transplantation
Volume56
Issue number9
DOIs
Publication statusPublished - Sep 2021

All Science Journal Classification (ASJC) codes

  • Hematology
  • Transplantation

Cite this